[1]
“Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients”, IJKD, vol. 5, no. 5, pp. 342–346, Aug. 2011, Accessed: Jun. 18, 2024. [Online]. Available: https://www.ijkd.org/index.php/ijkd/article/view/364